The Role of Wharton’s Jelly Mesenchymal Stem Cells in Diabetes Mellitus
暂无分享,去创建一个
[1] J. Chai,et al. The Role of Wharton’s Jelly Mesenchymal Stem Cells in Skin Reconstruction , 2015 .
[2] E. Michalopoulos,et al. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank , 2014, Transfusion.
[3] G. Chrousos,et al. Pancreatic Islet Cell Transplantation: An Update , 2013, Annals of Biomedical Engineering.
[4] M. Conconi,et al. Phenotype and Differentiation Potential of Stromal Populations Obtained from Various Zones of Human Umbilical Cord: An Overview , 2011 .
[5] M. Foss,et al. Stem cell therapy for diabetes mellitus , 2011, Kidney international supplements.
[6] Tian-hua Huang,et al. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. , 2011, Chinese medical journal.
[7] S. Matsumoto. Islet cell transplantation for Type 1 diabetes , 2010, Journal of diabetes.
[8] C. di Ilio,et al. Proteome analysis of human Wharton's jelly cells during in vitro expansion , 2010, Proteome Science.
[9] M. Côrrea-Giannella,et al. Pancreatic islet transplantation , 2009, Diabetology & metabolic syndrome.
[10] G. Warnock,et al. Adult stem or progenitor cells in treatment for type 1 diabetes: current progress. , 2007, Canadian journal of surgery. Journal canadien de chirurgie.
[11] Q. Xie,et al. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. , 2005, Chinese medical journal.
[12] H. Kolb,et al. An immune origin of type 2 diabetes? , 2005, Diabetologia.
[13] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .